Wen Zhou
- Molecular Biology top 10%
- Oncology top 10%
- Cancer Research top 5%
- Genetics
- Immunology
- Topics
- Histone Deacetylase Inhibitors Research (8 papers)Epigenetics and DNA Methylation (8 papers)Cancer-related Molecular Pathways (7 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Wen Zhou
47 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 1.2k
- Oncology 427
- Cancer Research 316
- Genetics 152
- Immunology 103
Countries citing papers authored by Wen Zhou
This map shows the geographic impact of Wen Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Zhou more than expected).
Fields of papers citing papers by Wen Zhou
This network shows the impact of papers produced by Wen Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Zhou. The network helps show where Wen Zhou may publish in the future.
Co-authorship network of co-authors of Wen Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Wen Zhou. A scholar is included among the top collaborators of Wen Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Zhou. Wen Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 25 | |
| 2 | 10 | |
| 3 | 1 | |
| 4 | 16 | |
| 5 | 1 | |
| 6 | 6 | |
| 7 | The Anti-Breast Cancer Effect and Mechanism of Glimepiride-Metformin Adduct | 1 |
| 8 | 19 | |
| 9 | 18 | |
| 10 | 37 | |
| 11 | 97 | |
| 12 | 46 | |
| 13 | 21 | |
| 14 | 50 | |
| 15 | 33 | |
| 16 | 19 | |
| 17 | 50 | |
| 18 | 6 | |
| 19 | 59 | |
| 20 | 50 |
About Wen Zhou
Wen Zhou is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 48 papers that have together received 1.6k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (8 papers), Epigenetics and DNA Methylation (8 papers) and Cancer-related Molecular Pathways (7 papers). The work is most often cited by research in Cancer Research (316 citations), Molecular Biology (1.2k citations) and Geriatrics and Gerontology (64 citations). Wen Zhou has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Joyce M. Slingerland, Wei‐Guo Zhu, Haiying Wang, Ying Zhao, Lipeng Wu, Yu Yu, Shaoli Lu, Xiaoxia Zhu, Guolin Chai and Lian Li. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.